Ameriprise Financial Inc Dexcom Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Dexcom Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 2,284,627 shares of DXCM stock, worth $175 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,284,627

Previous 3,332,318 31.44%

Holding current value

$175 Million

Previous $378 Million 59.47%

% of portfolio

0.04%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $67.1 Million - $122 Million	-1,047,691 Reduced 31.44%	2,284,627 $153 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $61.2 Million - $77.9 Million	-554,456 Reduced 14.27%	3,332,318 $378 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $32.6 Million - $40 Million	-285,243 Reduced 6.84%	3,886,774 $539 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $160 Million - $263 Million	2,122,184 Added 103.53%	4,172,017 $518 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $17.8 Million - $28.5 Million	-206,617 Reduced 9.16%	2,049,833 $191 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $63.7 Million - $74.2 Million	566,591 Added 33.53%	2,256,450 $290 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $10.4 Million - $12.3 Million	99,680 Added 6.27%	1,689,859 $196 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $67.2 Million - $97 Million	790,411 Added 98.83%	1,590,179 $180 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $6.28 Million - $7.74 Million	82,206 Added 11.46%	799,768 $64.5 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $36.6 Million - $71.6 Million	539,037 Added 301.94%	717,562 $53.4 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $9.86 Million - $13.7 Million	104,847 Added 142.3%	178,525 $91.2 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $2.31 Million - $2.9 Million	17,788 Added 31.83%	73,678 $38.9 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $3.22 Million - $4.32 Million	-30,157 Reduced 35.05%	55,890 $30.6 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $1.95 Million - $2.6 Million	-24,095 Reduced 21.88%	86,047 $36.8 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $4 Million - $4.95 Million	-47,222 Reduced 30.01%	110,142 $39.8 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $1.28 Million - $1.72 Million	16,451 Added 11.67%	157,364 $58.2 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $2.09 Million - $2.48 Million	21,922 Added 18.42%	140,913 $58.1 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $32,907 - $55,303	525 Added 0.44%	118,991 $48.2 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $356,513 - $564,199	-7,460 Reduced 5.92%	118,466 $31.9 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $508,285 - $795,185	13,880 Added 12.39%	125,926 $27.5 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $16,485 - $20,323	-464 Reduced 0.41%	112,046 $16.7 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $277,898 - $388,499	-9,982 Reduced 8.15%	112,510 $16.9 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $1.14 Million - $1.55 Million	-40,488 Reduced 24.84%	122,492 $14.3 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $1.02 Million - $1.41 Million	37,720 Added 30.11%	162,980 $19.5 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $710,283 - $1.12 Million	30,419 Added 32.07%	125,260 $17.9 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $1.44 Million - $2.08 Million	82,331 Added 658.12%	94,841 $9.01 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $9,337 - $13,256	-715 Reduced 5.41%	12,510 $928,000
Q4 2017 Feb 12, 2018	SELL	$11.12 - $15.38 $131,582 - $181,991	-11,833 Reduced 47.22%	13,225 $759,000
Q3 2017 Nov 07, 2017	BUY	$11.36 - $18.98 $284,658 - $475,600	25,058	25,058 $1.09 Million

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Dexcom Inc Transaction History